Developer docs
API playgroundTry for free, no card

Search company profiles

BioFortis

Full company profile

uuid000nes2

Namestring
BioFortis
Legal namestring
IQVIA
Websiteurl
biofortis.com
Company typeenum
Public
Founded yearint
2002
Descriptiontext

BioFortis is described in firmographic data as a private precision medicine software solutions provider, founded in 2002 and headquartered in Columbia, United States, with 11-50 employees. The substantive source material provided relates to IQVIA Laboratories (IQVIA's laboratory services division), and the recorded legal name for BioFortis in the source resolves to "IQVIA," which suggests a corporate affiliation; the data does not, however, contain direct BioFortis-specific operational facts.

Based on the available source content, the documented operating profile centers on a B2B enterprise service platform spanning central laboratory services, digital technologies (including Labmatrix clinical trial sample management), a clinical genomics laboratory, discovery sciences, bioanalytical laboratories with LC-MS capabilities, biomarker services, and vaccine laboratory services. The core technology stack combines specialty lab services with next-generation lab technologies, including an AI-driven digital pathology capability delivered through a strategic collaboration with OracleBio, and an e-Requisition workflow product (Site Lab Navigator) for sponsors and investigator sites.

The go-to-market is enterprise field sales targeting pharmaceutical and biotechnology companies across drug discovery and development stages, delivered through a horizontal segmentation approach. Pricing is not publicly disclosed and is negotiated via direct consultation, consistent with a B2B services model that monetizes per-study, per-specimen, and per-assay engagements rather than seat-based subscription software. Marketing leverages industry conferences, webinars, thought leadership content, and a dedicated careers portal, while distribution is direct-to-enterprise.

Short descriptiontext

BioFortis is described as a private precision medicine software solutions provider based in Columbia, United States. Its operational data ties to laboratory services and AI-enabled clinical trial workflow tooling serving pharmaceutical and biotechnology sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersColumbia, United States
HQ citystring
Columbia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
precision medicine software, clinical research analytics, biomarker data management, translational research software, genomics analytics platform
Industry3 codes
1Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
CodeHLAGAJAHPrimaryYes
2Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryNo
3Bioinformatics & Multi-omics Analysis Software
CodeHLAGAJADPrimaryNo
NAICS code1 code
  • Software Publishers51321
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Precision Medicine Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Services
TypeProfessional Services
Description

Provides comprehensive central laboratory services, specialty biomarker services, bioanalytical services, and vaccine laboratory services to pharmaceutical and biotech companies throughout drug discovery and development stages

labs.iqvia.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BioFortis provides precision medicine software solutions that support translational and clinical research workflows, including analytics and data management for biomarker and genomics-driven studies. The company's offering is aimed at pharmaceutical, biotechnology, and academic research teams that need software infrastructure to manage and analyze precision medicine data.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

IQVIA Laboratories is a global leader in drug discovery and development laboratory services, offering a comprehensive suite of central laboratory and specialty biomarker services. The portfolio includes Central Laboratory Services, Digital Technologies (including Labmatrix for clinical trial sample management), Clinical Genomics Laboratory, Discovery Sciences, Bioanalytical Laboratories (with LC-MS capabilities for small and large molecules), Biomarker Services, and Vaccine Laboratory Services. The company operates as an integrated platform combining in-depth scientific expertise, operational excellence, and next-generation lab technologies to support pharmaceutical and biotech clients throughout drug discovery and development stages.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1OracleBio
Strategic tierCoreTypeTechnology or Integration
Description

IQVIA Laboratories has formed a strategic collaboration with OracleBio to advance AI-driven digital pathology. The partnership integrates OracleBio's advanced AI image analysis capabilities to enhance clinical insights in digital pathology, improving the company's service offerings for pharmaceutical and biotech clients.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Veeva Systems
TypeDirect peer
Description

Veeva's Vault CDMS, Vault EDC, and Vault CTMS are the closest direct peers to BioFortis for pharma clinical-trial and lab data management, including sample tracking integrations. Both sell regulated, sponsor-grade software into the same pharma/biotech buyer.

2Medidata (Dassault Systèmes)
TypeDirect peer
Description

Medidata's Rave EDC/CTMS and biospecimen management capabilities compete head-to-head with Labmatrix-style sample-management software in sponsor clinical-trial deployments, and target the same precision-medicine and biomarker-driven trial designs.

3Benchling
TypeDirect peer
Description

Benchling is a cloud life-sciences R&D platform covering sample/biomolecule management, registry, and traceability — directly adjacent to BioFortis Labmatrix for translational and biomarker workflows in pharma and biotech.

4LabVantage Solutions
TypeDirect peer
Description

LabVantage provides LIMS and biobank/ biorepository informatics for regulated life-sciences labs, directly mirroring BioFortis's chain-of-custody and sample-tracking core.

5STARLIMS (Abbott)
TypeDirect peer
Description

STARLIMS is an established clinical/research LIMS used by hospital and biobank labs; it competes with Labmatrix in regulated laboratory informatics and sample management.

6Oracle Health Sciences (Clinical One / Siebel CTMS)
TypeBroad incumbent
Description

Oracle offers a broad eClinical/CTMS suite aimed at pharma sponsors; it is a broader incumbent than BioFortis but competes for the same translational informatics wallet, especially where lab/sample data integrate with EDC.

7Dotmatics
TypeEmerging player
Description

Dotmatics provides scientific informatics for biology R&D, including sample and registry tracking, positioning it as an emerging alternative to Labmatrix-style biorepository software inside translational programs.

8Arxspan (Bruker)
TypeEmerging player
Description

Arxspan's electronic laboratory notebook and registry software targets biopharma research data, with sample and assay tracking features that overlap BioFortis's translational research and biorepository functionality.

9Thermo Fisher SampleManager
TypeBroad incumbent
Description

Thermo Fisher's SampleManager LIMS bundles sample and biobank management into the instrument vendor's stack — a broader incumbent whose instrument-tied LIMS competes with Labmatrix at pharma/biotech biorepositories.

10Flatiron Health
TypeRegional player
Description

Flatiron focuses on oncology-specific clinical and real-world data, complementing BioFortis's precision-medicine use cases with deep tumor profiling, and they often appear together in oncology translational programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioFortis

Precision Medicine Softwarebiofortis.com

BioFortis is described as a private precision medicine software solutions provider based in Columbia, United States. Its operational data ties to laboratory services and AI-enabled clinical trial workflow tooling serving pharmaceutical and biotechnology sponsors.

What BioFortis does

BioFortis is described in firmographic data as a private precision medicine software solutions provider, founded in 2002 and headquartered in Columbia, United States, with 11-50 employees. The substantive source material provided relates to IQVIA Laboratories (IQVIA's laboratory services division), and the recorded legal name for BioFortis in the source resolves to "IQVIA," which suggests a corporate affiliation; the data does not, however, contain direct BioFortis-specific operational facts.

Based on the available source content, the documented operating profile centers on a B2B enterprise service platform spanning central laboratory services, digital technologies (including Labmatrix clinical trial sample management), a clinical genomics laboratory, discovery sciences, bioanalytical laboratories with LC-MS capabilities, biomarker services, and vaccine laboratory services. The core technology stack combines specialty lab services with next-generation lab technologies, including an AI-driven digital pathology capability delivered through a strategic collaboration with OracleBio, and an e-Requisition workflow product (Site Lab Navigator) for sponsors and investigator sites.

The go-to-market is enterprise field sales targeting pharmaceutical and biotechnology companies across drug discovery and development stages, delivered through a horizontal segmentation approach. Pricing is not publicly disclosed and is negotiated via direct consultation, consistent with a B2B services model that monetizes per-study, per-specimen, and per-assay engagements rather than seat-based subscription software. Marketing leverages industry conferences, webinars, thought leadership content, and a dedicated careers portal, while distribution is direct-to-enterprise.

BioFortis firmographics

Firmographics
Name
BioFortis
Legal name
IQVIA
Website
https://biofortis.com
Company type
Public
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
BioFortis is described as a private precision medicine software solutions provider based in Columbia, United States. Its operational data ties to laboratory services and AI-enabled clinical trial workflow tooling serving pharmaceutical and biotechnology sponsors.
Ownership category
akta.pro rank

BioFortis industry classification

Industry
Product category
Precision Medicine Software
NAICS
Software Publishers (51321)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH)
akta.pro secondary industries
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

Keywords

  • Precision medicine software
  • Clinical research analytics
  • Biomarker data management
  • Translational research software
  • Genomics analytics platform

Where BioFortis is headquartered

Location

Headquarters

HQ city
Columbia
HQ country
United States
HQ region
North America

Markets served

BioFortis business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Laboratory Services: Provides comprehensive central laboratory services, specialty biomarker services, bioanalytical services, and vaccine laboratory services to pharmaceutical and biotech companies throughout drug discovery and development stages

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

BioFortis product offering

Product offering

Core offering

BioFortis provides precision medicine software solutions that support translational and clinical research workflows, including analytics and data management for biomarker and genomics-driven studies. The company's offering is aimed at pharmaceutical, biotechnology, and academic research teams that need software infrastructure to manage and analyze precision medicine data.

Product overview

IQVIA Laboratories is a global leader in drug discovery and development laboratory services, offering a comprehensive suite of central laboratory and specialty biomarker services. The portfolio includes Central Laboratory Services, Digital Technologies (including Labmatrix for clinical trial sample management), Clinical Genomics Laboratory, Discovery Sciences, Bioanalytical Laboratories (with LC-MS capabilities for small and large molecules), Biomarker Services, and Vaccine Laboratory Services. The company operates as an integrated platform combining in-depth scientific expertise, operational excellence, and next-generation lab technologies to support pharmaceutical and biotech clients throughout drug discovery and development stages.

Differentiator

Problem solved

Functional benefit

Companies that use BioFortis

Customer profile

Segments2 records

Ideal customer profiles1 record

BioFortis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature2 records

BioFortis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • OracleBiocoreTechnology or IntegrationIQVIA Laboratories has formed a strategic collaboration with OracleBio to advance AI-driven digital pathology. The partnership integrates OracleBio's advanced AI image analysis capabilities to enhance clinical insights in digital pathology, improving the company's service offerings for pharmaceutical and biotech clients.

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

BioFortis competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva's Vault CDMS, Vault EDC, and Vault CTMS are the closest direct peers to BioFortis for pharma clinical-trial and lab data management, including sample tracking integrations. Both sell regulated, sponsor-grade software into the same pharma/biotech buyer.
  • Medidata (Dassault Systèmes): Medidata's Rave EDC/CTMS and biospecimen management capabilities compete head-to-head with Labmatrix-style sample-management software in sponsor clinical-trial deployments, and target the same precision-medicine and biomarker-driven trial designs.
  • Benchling: Benchling is a cloud life-sciences R&D platform covering sample/biomolecule management, registry, and traceability — directly adjacent to BioFortis Labmatrix for translational and biomarker workflows in pharma and biotech.
  • LabVantage Solutions: LabVantage provides LIMS and biobank/ biorepository informatics for regulated life-sciences labs, directly mirroring BioFortis's chain-of-custody and sample-tracking core.
  • STARLIMS (Abbott): STARLIMS is an established clinical/research LIMS used by hospital and biobank labs; it competes with Labmatrix in regulated laboratory informatics and sample management.

Broad incumbents

  • Oracle Health Sciences (Clinical One / Siebel CTMS): Oracle offers a broad eClinical/CTMS suite aimed at pharma sponsors; it is a broader incumbent than BioFortis but competes for the same translational informatics wallet, especially where lab/sample data integrate with EDC.
  • Thermo Fisher SampleManager: Thermo Fisher's SampleManager LIMS bundles sample and biobank management into the instrument vendor's stack — a broader incumbent whose instrument-tied LIMS competes with Labmatrix at pharma/biotech biorepositories.

Emerging players

  • Dotmatics: Dotmatics provides scientific informatics for biology R&D, including sample and registry tracking, positioning it as an emerging alternative to Labmatrix-style biorepository software inside translational programs.
  • Arxspan (Bruker): Arxspan's electronic laboratory notebook and registry software targets biopharma research data, with sample and assay tracking features that overlap BioFortis's translational research and biorepository functionality.

Regional players

  • Flatiron Health: Flatiron focuses on oncology-specific clinical and real-world data, complementing BioFortis's precision-medicine use cases with deep tumor profiling, and they often appear together in oncology translational programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

BioFortis social profiles

Digital presence

BioFortis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioFortis leadership team

Management profile

Number of profiles

BioFortis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioFortis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioFortis

What does BioFortis do?

BioFortis provides precision medicine software solutions that support translational and clinical research workflows, including analytics and data management for biomarker and genomics-driven studies. The company's offering is aimed at pharmaceutical, biotechnology, and academic research teams that need software infrastructure to manage and analyze precision medicine data.

Is BioFortis a public or private company?

BioFortis is a public company. It is classified as unknown and is currently operating.

When was BioFortis founded?

BioFortis was founded in 2002. It employs 11 to 50 people.

Where is BioFortis based?

BioFortis is headquartered in Columbia, United States, in the North America region.

How does BioFortis make money?

One revenue line is on record: laboratory Services.

Who are BioFortis's main competitors?

Direct peers on record are Veeva Systems, Medidata (Dassault Systèmes), Benchling, LabVantage Solutions and STARLIMS (Abbott). Broad incumbents are Oracle Health Sciences (Clinical One / Siebel CTMS) and Thermo Fisher SampleManager. Emerging players are Dotmatics and Arxspan (Bruker). Flatiron Health is listed as a regional player.

Does BioFortis have an API?

No public API is recorded for BioFortis.

What industry is BioFortis in?

BioFortis's product category is Precision Medicine Software. Its primary akta.pro industry code is HLAGAJAH, Sample / Biorepository & Biobank Informatics (Chain-of-Custody), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 51321 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals